BETTER B: BETter TreatmEnts for Refractory Breathlessness Oct 1, 2016 - Mar 31, 2018
Breathlessness is a common, distressing, symptom in advanced disease, causing considerable disability for patients,1, 2 and anxiety and social isolation for them and their family and carers.3-5 Breathlessness (also called dyspnea or dyspnoea) is usua...
Read More about BETTER B: BETter TreatmEnts for Refractory Breathlessness.
Projects (482)
Characterisation of monocyte CD200R in pulmonary sarcoidosis Mar 1, 2016 - Feb 28, 2018
AQUEDUCT Mar 1, 2016 - Nov 30, 2023
Evaluation of a complex intervention of journeying through dementia, with internal pilot trial with Dec 1, 2015 - Nov 30, 2019
Living with Long Term Illness project: Group work in Primary Care Dec 1, 2013 - Jul 31, 2019
This application has arisen as a result of the applicant (Jackson) identifying a problem in clinical practice, developing a solution (Long Term Illness Groups) and engaging in some preliminary evaluation. As a result of this, there is now interest in...
Read More about Living with Long Term Illness project: Group work in Primary Care.
PRIDE Mar 1, 2014 - Feb 28, 2019
People with dementia lose much more than just their memory and daily living skills. They can also lose their independence, their dignity and status, their confidence and morale, and their roles both within the family and beyond. They can often be see...
Read More about PRIDE.
Caring together evaluation project Dec 1, 2014 - Aug 1, 2016
C-Screening: Cervical cancer screening in older women aged 55 – 64 years old Mar 1, 2016 - Feb 28, 2019
The purpose of this study is to explore cervical screening amongst older women (55-64 years) living in Yorkshire. We will investigate the views and experiences of women regarding cervical screening and explore the attitudes of healthcare professional...
Read More about C-Screening: Cervical cancer screening in older women aged 55 – 64 years old.
PARAGON: A multicenter, randomized, double-blind, parallel group, active-controlled study to evaluate the efficacy and safety of LCZ696 compared to valsartan, on morbidity and mortality in heart failure patients (NYHA Class II-IV) with preserved ejection fraction Apr 1, 2015 - Mar 31, 2020
Cardiovascular (CV) disease is the leading cause of death in the western world. Heart failure (HF) incidence approaches 10 per 1000 population after 65 years of age in the United States (US) (Roger et al 2012) with HF prevalence between 2 and 3% in E...
Read More about PARAGON: A multicenter, randomized, double-blind, parallel group, active-controlled study to evaluate the efficacy and safety of LCZ696 compared to valsartan, on morbidity and mortality in heart failure patients (NYHA Class II-IV) with preserved ejection fraction.
Cardiogoniometry Studies Apr 1, 2016 - Dec 31, 2017
Service Users perspectives to accessing Type 2 Diabetes Services within East Riding of Yorkshire Jan 1, 2016 - Mar 31, 2019
adaptation of pfact 7856, which was a successful bid to Hull CCG. This is the same project for East Riding of Yorkshire CCG. Peer review for previous project attached.
At the boundaries of misattribution: Exploring boundary conditions of the positivity-familiarity effect Jan 1, 2018 - Dec 31, 2018
When people need to make judgments under uncertainty they often rely on cues. For example, when trying to answer the question of whether we like a certain object we might rely on the positive feelings that are associated with the fluency of processin...
Read More about At the boundaries of misattribution: Exploring boundary conditions of the positivity-familiarity effect.
Differentiating the malignant potential of pancreatic cysts Oct 1, 2017 - Dec 31, 2022
The effective diagnosis of pancreatic cancer is often quite challenging, due to a lack of disease-specific symptoms, resulting in the majority of patients presenting with advanced disease, with an associated dismal prognosis. Earlier detection of pan...
Read More about Differentiating the malignant potential of pancreatic cysts.
An evaluation of the CAMS - Collaborative Assessment and Management of Suicidality Apr 1, 2018 - Mar 31, 2021
This study will conduct the first evaluation of the psychosocial impact of a new therapeutic framework (Collaborative Assessment and Management of Suicidality - CAMS) on patients and clinicians in the National Health Service (NHS). CAMS, developed in...
Read More about An evaluation of the CAMS - Collaborative Assessment and Management of Suicidality.